January 1, 2010Thrombosis and Haemostasis
New-onset atrial fibrillation and warfarin initiation: High risk periods and implications for new antithrombotic drugs
View Full Paper
Ask AI
Bookmark
Share
Key result
No clinical study data is present in the provided text, which consists only of journal editorial board information.
Population
Patients with newly diagnosed atrial fibrillation and those without prior exposure to anticoagulation
Comparison
New anti-thrombotic agents / anticoagulant… vs Warfarin
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
No study data available in review; leaves open optimal anticoagulation start in new AF and need for naive-patient trials.
Key Points
- This review aims to identify high-risk periods for bleeding and thromboembolism in patients newly diagnosed with atrial fibrillation.
- Review of recent clinical trials and literature on atrial fibrillation and warfarin
- Analysis of risks associated with warfarin initiation and new anticoagulants
- Recommendation for including patients without prior anticoagulation exposure in trials
- Risk of bleeding and stroke is highest during new atrial fibrillation diagnosis and anticoagulant initiation
- New anticoagulant trials often enroll patients already on warfarin, potentially skewing results
- Substantial inclusivity of patients without prior anticoagulation could enhance safety and efficacy assessments of new therapies
Structured PICO
P
Population
Patients with newly diagnosed atrial fibrillation and those without prior exposure to anticoagulation
I
Intervention
New anti-thrombotic agents / anticoagulant medication
C
Comparator
Warfarin
O
Outcome
Haemorrhage and strokehard clinical
The risk of hemorrhage and stroke is highest during the initial diagnosis of atrial fibrillation and initiation of anticoagulation, highlighting the need for future trials to include anticoagulant-naive patients.
Cite This Study
Lópes et al. (2010) studied this question. No clinical study data is present in the provided text, which consists only of journal editorial board information.
Topics
View Full Paper
Ask AI
Bookmark
Share